BIVI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioVie Inc (BIVI) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or trends to suggest immediate upside potential. A hold position is recommended until more favorable conditions or signals emerge.
The MACD is slightly positive and expanding, indicating weak bullish momentum. RSI is neutral at 57.883, suggesting no overbought or oversold conditions. Moving averages are converging, showing no clear trend. Key support is at 1.358, and resistance is at 1.493. The stock is trading near its pivot point of 1.425, indicating indecision in the market.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress.
Weak financial performance in Q2 2026, with a YoY net income drop of -15.19% and EPS declining by -83.08%. No recent news or influential trading data to drive sentiment. Stock trend analysis suggests a low probability of significant short-term gains.
In Q2 2026, BioVie reported no revenue growth (0% YoY) and a net income loss of -6,069,475 (-15.19% YoY). EPS dropped significantly by -83.08% YoY to -0.77. Gross margin remains at 0%, showing no improvement in profitability.
No analyst rating or price target changes available for BioVie Inc.
